Right now, the Generation Study is looking for people ages 60 to 75 who have normal memory and thinking ability but may have a higher risk of developing the disease based on their genetic background.
Our study is investigating medications that could advance doctors' understanding of how to potentially prevent the onset of Alzheimer's disease. By joining this study, you could help impact the future of medicine. Qualified participants may also receive genetic counseling, study medication, and study-related care at no cost.
If you're interested in learning more, click here to take our simple,
no-commitment questionnaire to see if you may be eligible.
Along with participation from people like you, this study brings together some of the best and brightest organizations in the Alzheimer's community:
The study is sponsored by Novartis, a Swiss pharmaceutical company, and Amgen, a biotechnology company based in Thousand Oaks, CA, in collaboration with BAI, with funding from the National Institute on Aging, part of the National Institutes of Health (NIH), as well as the Alzheimer’s Association, FBRI, GHR Foundation and Banner Alzheimer’s Foundation.